This system is used to describe the anatomical extent of the disease at diagnosis based on primary tumor size and extent of tumor growth (T), regional lymph node metastasis (N) and distant metastasis (M), and is the basis for stage grouping these patients [ 7, 8].
Third, the score may provide a basis for future staging systems for stage II colon cancer to which recognized tumor prognostic factors such as intra or extramural vascular invasion, peritoneal involvement, margin involvement, tumor perforation, tumor grade, number of examined lymph nodes, inflammation-based scores (e.g., modified/optimized Glasgow Prognostic Score), and comorbidity might be added.
Cancer patients were enrolled among those who were planned to undergo a whole-body [18 F]FDG-PET/CT on a clinically routine basis for cancer staging or to monitor the disease after treatment.
The relative waist circumference may provide a basis for future staging systems for dogs with heart disease, to which further discriminatory variables might be added.
Third, the score may provide a basis for future staging systems for Dukes B colorectal cancer to which further discriminatory variables might be added.
Widespread utilization of these simple laboratory measures has facilitated earlier recognition of DKD and has formed the basis for clinical staging.
Such a classification needs to be applicable and transparent in all parts of the world, and would allow for comparison of experiences and serve as a basis for disease staging in clinical trials in chronic pancreatitis.
Depositions of both aggregated Aß and tau are not distributed randomly throughout the brain but rather follow a highly predictive pattern of progression which provides the basis for neuropathological staging of the disease [ 1, 2].
These findings suggest that GRPR may be used as a molecular basis for diagnosing and staging PC, similar to somatostatin receptors (SST) which are being successfully used in clinical practice [ 9– 12].
